SCHOTT Pharma AG & Co KgaA
XETRA:1SXP

Watchlist Manager
SCHOTT Pharma AG & Co KgaA Logo
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
Watchlist
Price: 24.76 EUR 1.81% Market Closed
Market Cap: 3.7B EUR
Have any thoughts about
SCHOTT Pharma AG & Co KgaA?
Write Note

Balance Sheet

Balance Sheet Decomposition
SCHOTT Pharma AG & Co KgaA

Current Assets 586m
Cash & Short-Term Investments 29.5m
Receivables 380.5m
Other Current Assets 176m
Non-Current Assets 813.1m
Long-Term Investments 84.9m
PP&E 679.7m
Intangibles 30.6m
Other Non-Current Assets 17.9m
Current Liabilities 415.6m
Accounts Payable 91m
Accrued Liabilities 53m
Other Current Liabilities 271.6m
Non-Current Liabilities 215.9m
Long-Term Debt 81.1m
Other Non-Current Liabilities 134.8m

Balance Sheet
SCHOTT Pharma AG & Co KgaA

Rotate your device to view
Balance Sheet
Currency: EUR
Sep-2020 Sep-2021 Sep-2022 Sep-2023
Assets
Cash & Cash Equivalents
19
28
29
24
Cash
0
0
0
0
Cash Equivalents
18
28
29
24
Short-Term Investments
1
0
2
4
Total Receivables
153
187
385
285
Accounts Receivables
131
151
199
224
Other Receivables
23
36
186
61
Inventory
63
84
129
139
Other Current Assets
3
3
10
16
Total Current Assets
239
302
555
468
PP&E Net
267
334
517
638
PP&E Gross
267
334
517
638
Accumulated Depreciation
350
375
462
489
Intangible Assets
3
2
2
1
Goodwill
28
29
31
29
Note Receivable
0
0
0
0
Long-Term Investments
50
62
80
79
Other Long-Term Assets
10
10
12
15
Other Assets
28
29
31
29
Total Assets
596
N/A
740
+24%
1 197
+62%
1 232
+3%
Liabilities
Accounts Payable
62
63
100
91
Accrued Liabilities
35
43
57
64
Short-Term Debt
1
1
2
1
Current Portion of Long-Term Debt
1
1
3
3
Other Current Liabilities
111
136
161
193
Total Current Liabilities
210
244
323
351
Long-Term Debt
3
2
71
69
Deferred Income Tax
8
12
21
25
Minority Interest
1
2
2
2
Other Liabilities
59
62
72
94
Total Liabilities
282
N/A
322
+14%
489
+52%
541
+11%
Equity
Common Stock
0
0
26
151
Retained Earnings
0
0
131
494
Other Equity
315
418
551
45
Total Equity
315
N/A
418
+33%
707
+69%
690
-2%
Total Liabilities & Equity
596
N/A
740
+24%
1 197
+62%
1 232
+3%
Shares Outstanding
Common Shares Outstanding
151
151
151
151

See Also

Discover More